Clik here to view.
三叶草生物制药在研1类新药SCB-313在中国开展的恶性胸水I期临床完成首例患者给药
成都 (美国商业资讯)–三叶草生物制药，一家全球临床阶段，致力于创新及变革性生物制药研发的生物制药公司，今天宣布在中国进行的又一个SCB-313 I期临床试验完成首例患者给药。SCB-313是一种创新重组人肿瘤坏死因子相关凋亡诱导配体（TRAIL）-...
View ArticleClik here to view.
Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in...
CHENGDU, China Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was...
View ArticleClik here to view.
Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe
DUBLIN & CAMBRIDGE, United Kingdom & BRISBANE, Australia Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple small molecule drugs that block harmful...
View ArticleClik here to view.
ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to...
DUBLIN ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced the signing of a...
View ArticleClik here to view.
Clik here to view.
Macrogen Signs License and Supply Agreement with Thermo Fisher Scientific
SEOUL, South Korea Kap-Seok Yang, CEO of Macrogen (KOSDAQ: 038290), announced on January 13 that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific. The...
View ArticleClik here to view.
ドキュメンタリーBLEED OUTの上映とパネルディスカッション
（ビジネスワイヤ） — 患者安全運動財団： 内容： ありふれた人工股関節部分置換手術を母親が受けて永久的脳障害を伴って昏睡状態になった後、息子さんのビデオ日記を市民らが調査して、米国医療の追及が始まりました。撮影が10年に及んだBLEED...
View ArticleClik here to view.
武田薬品：事業変革の進捗と優先事項の概要について第38回J.P. モルガン・ヘルスケア・カンファレンスにて発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 当社は、このたび、第38回J.P....
View ArticleClik here to view.
Takeda to Outline Progress on Business Transformation and Priorities at the...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) will provide an update on the progress of its business transformation and priorities today...
View ArticleClik here to view.
GeneMedicine Appoints MIT Professor Robert S. Langer, Sc.D to Its Scientific...
SEOUL, South Korea GeneMedicine Co., Ltd., a leader in the field of oncolytic adenovirus platform for the treatment of intractable cancers, announced today that the company has appointed Robert S....
View ArticleClik here to view.
Alpha Holdings Makes Superior, $39.3 Million Offer to OncoSec
SEONGNAM, South Korea Alpha Holdings, Inc. (KOSDAQ: 117670) (“Alpha”), the largest stockholder of OncoSec Medical Incorporated (NASDAQ: ONCS) (“OncoSec”), with an approximate 15.1% ownership stake,...
View ArticleClik here to view.
Lucence Presents Data Demonstrating Potential of AmpliMARK™-Powered...
MIAMI Singapore-based precision oncology startup Lucence, on the heels of its series A funding, is sharing early data highlighting the capabilities of its liquid biopsy technology to detect somatic...
View ArticleClik here to view.
武田将在第38届年度J.P.摩根健康产业大会上介绍业务转型和优先工作的进展情况
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TOKYO:4502/NYSE:TAK)（以下称“武田”）将于今日在第38届年度J.P.摩根健康产业大会(J.P. Morgan Healthcare...
View ArticleClik here to view.
Alpha Holdings Sends Open Letter to OncoSec Stockholders Answering Questions...
SEONGNAM, South Korea Alpha Holdings, Inc. (KOSDAQ: 117670) (“Alpha”), the largest stockholder of OncoSec Medical Incorporated (NASDAQ: ONCS) (“OncoSec”), with an approximate 15.1% ownership stake,...
View ArticleClik here to view.
Cyclica and AUM Biosciences to Partner on Developing Novel Cancer Therapies...
TORONTO & SINGAPORE AUM Biosciences (AUM), a Singapore-headquartered clinical-stage biotechnology company committed to speedily developing affordable cancer therapies, and Cyclica, a...
View ArticleClik here to view.
BLEED OUT纪录片放映和小组讨论会
(美国商业资讯) — 患者安全运动基金会： 事由： 在常规的部分髋关节置换术造成其母亲陷入昏迷伴永久性脑损伤后，一位儿子的视频日记成为人民对美国医疗保健的调查。BLEED OUT的摄制过程长达10年，采用了档案影片、真实场景、隐蔽的偷拍摄像机、法庭证词以及对家属和专家的采访，深入探讨这个有缺陷的医疗保健体制。 原因：...
View ArticleClik here to view.
INSERTING and REPLACING Alpha Holdings Sends Open Letter to OncoSec...
SEONGNAM, South Korea Insert new paragraph after the 1st paragraph under the “ADDITIONAL INFORMATION AND WHERE TO FIND IT“ section of the release. The corrected release reads: ALPHA HOLDINGS SENDS...
View ArticleClik here to view.
Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars...
SINGAPORE Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong. The partnership covers Samsung...
View ArticleClik here to view.
MEVION S250i Selected by Jinshazhou Hospital to Equip New Proton Therapy...
LITTLETON, Mass. Mevion Medical Systems is pleased to announce it has signed an agreement for the sale of a MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning to Jinshazhou...
View ArticleClik here to view.
Immervisionがレンズ・メーカーの韓国ACE Solutech Co., Ltd.および中国Zhonglan Electronic...
モントリオール （ビジネスワイヤ） — モントリオールを拠点に特許取得済み広角光学・イメージング技術を開発・ライセンスするImmervisionは、特許取得済みパノモーフ広角レンズの生産および販売に関する新たなライセンス契約を2件発表します。このレンズは解像度を強化しており、消費者向けアプリケーションとモバイル・アプリケーションに適しています。...
View Article